Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures - Schedule of Segment Reporting Information (Details)

v3.23.1
Segment Disclosures - Schedule of Segment Reporting Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
segment
Mar. 31, 2022
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 2  
Segment Reporting Information [Line Items]    
Revenue $ 4,122 $ 2,567
Cost of revenue 2,122 1,358
Gross profit 2,000 1,209
EksoHealth    
Segment Reporting Information [Line Items]    
Revenue 3,997 1,881
Cost of revenue 1,951 1,015
Gross profit 2,046 866
EksoWorks    
Segment Reporting Information [Line Items]    
Revenue 125 686
Cost of revenue 171 343
Gross profit $ (46) $ 343